Day: November 2, 2023

eXp World Holdings Reports Q3 2023 ResultseXp World Holdings, Inc., the holding company for eXp Realty®, Virbela and SUCCESS® Enterprises, today announced financial results for the third quarter ended Sept. 30, 2023.Agent Count Grew 5% Compared to Q3 2022 to More Than 89,000 Agents in 24 Global Markets International Realty Revenue Increased 47% Compared to Q3 2022 to an All-Time Record Company Declares Cash Dividend for Q4 2023 of $0.05 per Share of Common Stock BELLINGHAM, Wash., Nov. 02, 2023 (GLOBE NEWSWIRE) — eXp World Holdings, Inc. (Nasdaq: EXPI), or the “Company”, the holding company for eXp Realty®, Virbela and SUCCESS® Enterprises, today announced financial results for the third quarter ended Sept. 30, 2023. Third Quarter 2023 Consolidated Financial Highlights as Compared to the Same Year-Ago Quarter:Revenue...

Southampton, PA, Nov. 02, 2023 (GLOBE NEWSWIRE) — Quaint Oak Bancorp, Inc. (the “Company”) (OTCQB: QNTO), the holding company for Quaint Oak Bank (the “Bank”), announced today a net loss for the quarter ended September 30, 2023 of $255,000, or $0.11 per basic and diluted share, compared to net income of $2.6 million, or $1.29 per basic and $1.22 per diluted share for the same period in 2022. Net income for the nine months ended September 30, 2023 was $878,000, or $0.40 per basic and $0.39 per diluted share, compared to $6.7 million, or $3.27 per basic and $3.09 per diluted share for the same period in 2022. Robert T. Strong, President and Chief Executive Officer stated, “The recent actions of the Federal Reserve Bank have exacted a toll on the banking system, such as we have not experienced in modern history. The compression on...

Record quarterly production exceeds guidance, leads to increased full-year 2023 outlook Capital investments in quarter were below guidance Publishes 2023 Sustainability Report and inaugural Climate Risk and Resilience Report TULSA, OK, Nov. 02, 2023 (GLOBE NEWSWIRE) — Vital Energy, Inc. (NYSE: VTLE) (“Vital Energy” or the “Company”) today reported its third-quarter 2023 financial and operating results. Supplemental slides have been posted to the Company’s website and can be found at www.vitalenergy.com. A conference call and webcast is planned for 7:30 a.m. CT, Friday, November 3, 2023. Participation details can be found within this release. HighlightsAnnounced three Permian Basin acquisitions adding a combined 53,000 net acres and 150 gross high-value locations (Maple closed October 31; Henry and...

Dallas, Texas, Nov. 02, 2023 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today reported a net loss attributable to NL stockholders of $.1 million, or nil per share, in the third quarter of 2023 compared to a net loss attributable to NL stockholders of $8.9 million, or $.18 per share, in the third quarter of 2022. NL results include an unrealized gain of $.4 million in the third quarter of 2023 related to the change in value of marketable equity securities compared to an unrealized loss of $24.2 million in the third quarter of 2022. For the first nine months of 2023, NL reported a net loss attributable to NL stockholders of $9.9 million, or $.20 per share, compared to net income attributable to NL stockholders of $39.9 million, or $.82 per share, for the first nine months of 2022. NL results include an unrealized loss of $10.5...

Kalamazoo, Michigan, Nov. 02, 2023 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) reported operating results for the third quarter of 2023: Third Quarter ResultsReported net sales increased 9.6% to $4.9 billion Organic net sales increased 9.2% Reported operating income margin of 19.0% Adjusted operating income margin(1) increased 110 bps to 23.4% Reported EPS decreased 15.9% to $1.80 Adjusted EPS(1) increased 16.0% to $2.46  Third Quarter Net Sales Growth Overview  Reported   Foreign Currency Exchange   Constant Currency   Acquisitions / Divestitures   OrganicMedSurg and Neurotechnology         10.5         %           0.2         %           10.3         %           0.2         %           10.1         %Orthopaedics and Spine         8.4                     0.4                     8.0                     —                     8.0          Total         9.6         %           0.3         %           9.3         %           0.1         %           9.2         %“We...

SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company focused on developing targeted therapies designed to save lives and improve the standard of care for patients facing serious diseases, today reported financial results for the third quarter ended September 30, 2023 and provided an update on its corporate activities and product pipeline. “We are proud of the recent advancements of both the REZZAYO program as well as our Cloudbreak® drug-Fc conjugate (DFC) platform,” said Jeffrey Stein, Ph.D., president and chief executive officer of Cidara. “The US commercial launch of REZZAYO by our partner Melinta as well as the receipt by our ex-US/ex-Japan partner Mundipharma of the positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human...

Initiated a global Phase 2b trial to treat rheumatoid arthritis (RA) with rosnilimab, our PD-1 agonistInitiating in Q4 2023 a global Phase 2 trial to treat ulcerative colitis (UC) with rosnilimabAnnounced positive top-line Phase 3 clinical trial results of imsidolimab (IL-36R) in generalized pustular psoriasis (GPP)Reiterating cash runway through year-end 2026 and updating expected year-end 2023 cash and investments of $400 to $410 millionSAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported operating results for the third quarter ended September 30, 2023 and provided a business update. “We’ve made strong progress this quarter executing against our multi-year plan to develop best-in-class...

Quarterly revenue of $853 million; GAAP EPS of $1.39 and adjusted EPS of $1.97 DALLAS, Nov. 02, 2023 (GLOBE NEWSWIRE) — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2023 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts.  Q3 2023 % Change Q3 2022 YTD September 30, 2023 % Change YTD September 30, 2022Revenue $853.5 (25%) $2,971.0 (28%)Gross profit $289.5 (25%) $988.6 (26%)Net income $53.2 (42%) $198.2 (45%)GAAP diluted EPS $1.39 (34%) $4.99 (38%)Adjusted diluted EPS* $1.97 (23%) $6.86 (27%)Adjusted EBITDA* $133.7 (26%) $475.1 (29%)* See “Non-GAAP Measures” below for a discussion of our use of non-GAAP items and the table...

JACKSONVILLE, Fla., Nov. 02, 2023 (GLOBE NEWSWIRE) — Regency Centers Corporation (“Regency” or the “Company”) (Nasdaq: REG) today reported financial and operating results for the period ended September 30, 2023 and provided updated 2023 earnings guidance. For the three months ended September 30, 2023 and 2022, Net Income was $0.50 per diluted share and $0.51 per diluted share, respectively. Third Quarter 2023 HighlightsReported Nareit FFO of $1.02 per diluted share, which includes a $0.01 per diluted share impact for merger transition expense, and Core Operating Earnings of $0.97 per diluted share Raised 2023 full year Nareit FFO guidance to a range of $4.13 to $4.15 per diluted share and 2023 full year Core Operating Earnings guidance to a range of $3.93 to $3.95 per diluted share The midpoint of the updated 2023 Core Operating...